Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Oct 02, 2024
Beyond the shadow of a doubt, the Rheumatoid arthritis treatment market has witnessed strides of improvement during the last few years. There was a time when treatment for rheumatoid arthritis was confined to Non-steroidal anti-inflammatory drugs (NSAIDs) and steroids, which could only address pain and swelling. Ho...
Read More...
Dec 02, 2020
Rheumatoid Arthritis is a chronic inflammatory condition that causes pain, swelling and stiffness in the joints. It is an autoimmune disorder, in which the immune system mistakenly attacks the body tissues. If left untreated, it can lead to disability, decreased quality of life and premature mortality. As of now, t...
Read More...
Aug 14, 2014
DelveInsight’s, “ Rheumatoid Arthritis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufactu...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper